| 标题 |
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Uwe Platzbecker; Jan Moritz Middeke; Katja Sockel; Regina Herbst; Dominik Wolf; et al 出版日期:2018-11-12 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)